In December 2009, Clinova launched Stemaderm™ cream for the treatment of topical bacterial infections. The cream contains a combination of natural plant based ingredients. The product’s has a potent, broad spectrum antimicrobial activity. Clinova is currently marketing the product globally and expects to report strong sales for the product in 2010 and in 2011.
The following tables shows our clinical-stage compounds that we are developing internally or are co-developing with a partner. Please click the relevant codename for more information:
| Code Name | Brand Name | Indication | Pre Clinical | Pre Marketing (Early) | Pre Marketing (Middle) | Pre Marketing (Late) | Market Preparation / Launch |
|---|---|---|---|---|---|---|---|
| CLIN 3001 | Covaflu mask FFP2 | Pandemic Respirator | Complete |
Complete |
Complete |
Complete |
Current |
| CLIN 3002 | Covaflu mask FFP3 | Pandemic respirator | Complete |
Complete |
Complete |
Complete |
Current |
| CLIN 3003 | Quash | Hand Sanitizer | Complete |
Complete |
Complete |
Complete |
Current |
| CLIN 3004 | TBC | Painkiller | Complete |
Complete |
Complete |
Current |
Not reached |
| CLIN 3005 | Stemaderm™ Cream | Topical skincare cream | Complete |
Complete |
Complete |
Complete |
Current |
| CLIN 3011 | TBC | Indigestion remedy | Complete |
Complete |
Complete |
Current |
Not reached |
| CLIN 3012 | Repelsect ™ | Insect patch repellent | Complete |
Complete |
Complete |
Complete |
Current |
| CLIN 3018 | ORS | Effervescent Tablets | Complete |
Complete |
Complete |
Complete |
Current |